Skip to content
EU Startups News
  • Funding
  • Launch
  • Partnership
  • Acquisition
  • Policy
  • Exit & IPO

Kiro

French Hospitals Partner With Kiro on AI-Driven Clinical Decision Support Project

July 6, 2026 by Sophie Renard

French hospitals and startup Kiro launched OPTIMABIO, an AI project to improve hospital biology test prescriptions. The initiative, funded by Marseille, Lyon, and Limoges hospitals, aims to transform routine medical decisions using artificial intelligence.

Categories Funding Tags Artificial Intelligence, France, Growth, Healthtech, Kiro Leave a comment
Browse by Country

Latest

Swedish Pet Insurance Startup Lassie Secures Nearly 1 Billion Kronor in Fresh CapitalOct 7, 2026
Polish Creator Dawid Pałka's Public Experiment to Build Algorify Faces Scrutiny Over Profit ProjectionsOct 7, 2026
KickstartAI and Leiden University Launch AI Tool to Automate Wound Report DocumentationOct 7, 2026
Portuguese Healthtech Startup Usawa Care Raises $3 Million to Expand US OperationsOct 7, 2026
Dutch AI Startup Cori Clinical Raises $4 Million Seed Round to Accelerate Clinical Trial Design PlatformOct 7, 2026

EU Markets

European Fintech Expands, Crypto Matures, and Capital Shifts: What This Week's Financial News Means for StartupsOct 2, 2026
European Financial Markets Weekly: Billion-Dollar Raises, Banking Stress Tests, and What It All Means for Your StartupSep 25, 2026
Europe's Financial Markets Are Shifting — Here's What Startup Founders Need to Know This WeekSep 18, 2026
ECB Rate Hike, Banking M&A, and a Crypto Security Storm: What Europe's Financial Markets Mean for Startups This WeekSep 11, 2026

EU Startups News
• About Us • Privacy Policy

Follow Us

LinkedIn X / Twitter Facebook

Stay informed

Get the latest European startup news delivered to your inbox every week. For broader markets news, visit: EU Finance News

No spam. Unsubscribe anytime.

By continuing to use this site you agree to our Privacy Policy and the use of cookies.

© 2026 EU Startups News • Built with GeneratePress

By continuing to use this site you agree to our Privacy Policy and the use of cookies.